We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




3D Ultrasound Could Turn Autonomous Robot Surgery into a Reality

By HospiMedica staff writers
Posted on 19 May 2008
In the near future, robots may perform surgery on patients in dangerous situations or in remote locations, such as on the battlefield or in space, with minimal human guidance. More...


Researchers at Duke University (Durham, NC, USA) developed a rudimentary tabletop robot, which processes real-time three-dimensional (3D) information obtained via ‘eyes' based on a novel 3D ultrasound technology. An artificial intelligence (AI) program serves as the robot's brain, processing the information, giving the robot specific commands to perform. In one experiment, the robot successfully performed its main task, directing a needle on the end of the robotic arm to touch the tip of another needle within a blood vessel graft. The robot's needle was guided by a tiny 3D ultrasound transducer attached to a catheter commonly used in angioplasty procedures. The experiment was detailed in a study published in the May 2008 online issue of the journal IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control (TUFFC).

In earlier experiments, the tabletop robot arm successfully touched a needle on the arm to another needle in a water bath; then it performed a simulated biopsy of a cyst, fashioned out of a liquid-filled balloon in a medium designed to simulate tissue. The results of these experiments were published in the April 2008 edition of the journal Ultrasonic Imaging.

"Currently, cardiologists doing catheter-based procedures use fluoroscopy, which employs radiation, to guide their actions. Putting a 3D ultrasound transducer on the end of the catheter could provide clearer images to the physician and greatly reduce the need for patients to be exposed to radiation,” said Professor Stephen Smith, Ph.D., director of the Duke University ultrasound transducer group and senior member of the research team. "Given that we achieved these early results with a rudimentary robot and a basic artificial intelligence program, the technology will advance to the point where robots - without the guidance of the doctor - can someday operate on people.”

The researchers added that adding this 3D capability to more powerful and sophisticated surgical robots already in use at many hospitals could hasten the development of autonomous robots that could perform complex procedures on humans.


Related Links:
Duke University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.